Violeta B. Popov, Ph.D.

Affiliations: 
2014 Yale University, New Haven, CT 
Area:
General, Physiology Biology
Google:
"Violeta Popov"
Mean distance: (not calculated yet)
 

Parents

Sign in to add mentor
Gerald I. Shulman grad student 2014 Yale
 (Role of Beta-catenin in Regulating Hepatic Lipid Metabolism in NAFLD.)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Beddow SA, Gattu AK, Vatner DF, et al. (2018) PEPCK1 antisense oligonucleotide prevents adiposity and impairs hepatic glycogen synthesis in high-fat male fed rats. Endocrinology
Popov VB, Thompson CC, Kumar N, et al. (2016) Effect of Intragastric Balloons on Liver Enzymes: A Systematic Review and Meta-Analysis. Digestive Diseases and Sciences
Popov VB, Jornayvaz FR, Akgul EO, et al. (2015) Second-generation antisense oligonucleotides against β-catenin protect mice against diet-induced hepatic steatosis and hepatic and peripheral insulin resistance. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology
Popov VB, Lim JK. (2015) Treatment of Nonalcoholic Fatty Liver Disease: The Role of Medical, Surgical, and Endoscopic Weight Loss. Journal of Clinical and Translational Hepatology. 3: 230-238
Vatner DF, Snikeris J, Popov V, et al. (2015) 3,5 Diiodo-L-Thyronine (T2) Does Not Prevent Hepatic Steatosis or Insulin Resistance in Fat-Fed Sprague Dawley Rats. Plos One. 10: e0140837
Perry RJ, Kim T, Zhang XM, et al. (2013) Reversal of hypertriglyceridemia, fatty liver disease, and insulin resistance by a liver-targeted mitochondrial uncoupler. Cell Metabolism. 18: 740-8
Popov VB, Lim JK. (2011) Impact of insulin-sensitizing agents on risk for liver cancer and liver-related death in diabetic patients with compensated hepatitis C cirrhosis. The Journal of Clinical Endocrinology and Metabolism. 96: 2398-400
Lee HY, Birkenfeld AL, Jornayvaz FR, et al. (2011) Apolipoprotein CIII overexpressing mice are predisposed to diet-induced hepatic steatosis and hepatic insulin resistance. Hepatology (Baltimore, Md.). 54: 1650-60
See more...